The mechanism of aggrecan release from cartilage differs with tissue origin and the agent used to stimulate catabolism.

The mechanisms of aggrecan degradation in adult human articular, adult bovine nasal and fetal bovine epiphyseal cartilage in response to either interleukin-1beta (IL-1beta) or retinoic acid were compared using an explant culture system. Bovine nasal cartilage cultured with either IL-1beta or retinoic acid exhibited significant release of glycosaminoglycan (GAG). For both factors, aggrecan proteolysis occurred predominantly at the 'aggrecanase' site, with no evidence for the action of matrix metalloproteinases, and resulted in the appearance of the corresponding G1 fragment in tissue extracts and in culture media. In human cartilage, little effect of IL-1beta was seen, but abundant release of GAG occurred in the presence of retinoic acid, with evidence of aggrecanase action. Treatment of fetal epiphyseal cartilage with retinoic acid resulted in significant GAG release, whereas treatment with IL-1beta did not. In the retinoic acid-treated tissue, however, no evidence for the cleavage of aggrecan in the interglobular region was apparent. Thus, in the fetal system, agents in addition to aggrecanase and matrix metalloproteinases appear to be active. Taken together, these data demonstrate that the pathways utilized for aggrecan catabolism may vary between different cartilages for a given stimulatory agent, and that, for a given tissue, different factors may elicit aggrecan release via different pathways.

[1]  M. Tortorella,et al.  Age-related Changes in Aggrecan Glycosylation Affect Cleavage by Aggrecanase* , 2000, The Journal of Biological Chemistry.

[2]  J. Sandy,et al.  The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1 , 2000 .

[3]  M. Tiku,et al.  Evidence Linking Chondrocyte Lipid Peroxidation to Cartilage Matrix Protein Degradation , 2000, The Journal of Biological Chemistry.

[4]  T. Burn,et al.  Sites of Aggrecan Cleavage by Recombinant Human Aggrecanase-1 (ADAMTS-4)* , 2000, The Journal of Biological Chemistry.

[5]  P. Roughley,et al.  Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. , 1999, The Biochemical journal.

[6]  S. Scherer,et al.  Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31. , 1999, Genomics.

[7]  R. Wynn,et al.  Cloning and Characterization of ADAMTS11, an Aggrecanase from the ADAMTS Family* , 1999, The Journal of Biological Chemistry.

[8]  R. Wynn,et al.  Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. , 1999, Science.

[9]  D. Buttle,et al.  The use of cleavage site specific antibodies to delineate protein processing and breakdown pathways. , 1999, Molecular pathology : MP.

[10]  C. Little,et al.  Expression and activity of articular cartilage hyaluronidases. , 1998, Biochemical and biophysical research communications.

[11]  J. Mort,et al.  Immunolocalization of the cleavage of the aggrecan core protein at the Asn341–Phe342 bond, as an indicator of the location of the metalloproteinases active in the lysis of the rat growth plate , 1998, The Anatomical record.

[12]  M. Tiku,et al.  Hydroxyl radical formation in chondrocytes and cartilage as detected by electron paramagnetic resonance spectroscopy using spin trapping reagents. , 1998, Free radical research.

[13]  R. Bank,et al.  Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage. The age-related increase in non-enzymatic glycation affects biomechanical properties of cartilage. , 1998, The Biochemical journal.

[14]  R. Schneiderman,et al.  Aggrecan turnover in human articular cartilage: use of aspartic acid racemization as a marker of molecular age. , 1998, Archives of biochemistry and biophysics.

[15]  J. Kollár,et al.  Complete coding sequence of bovine aggrecan: comparative structural analysis. , 1997, Archives of biochemistry and biophysics.

[16]  L. Bonassar,et al.  Inhibition of cartilage degradation and changes in physical properties induced by IL-1beta and retinoic acid using matrix metalloproteinase inhibitors. , 1997, Archives of biochemistry and biophysics.

[17]  P. Roughley,et al.  Aggrecan degradation in human intervertebral disc and articular cartilage. , 1997, The Biochemical journal.

[18]  J. Weidner,et al.  Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. , 1997, The Journal of clinical investigation.

[19]  T. Cawston,et al.  Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage in culture. , 1995, Biochemical and biophysical research communications.

[20]  J. Weidner,et al.  VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis. , 1995, The Journal of clinical investigation.

[21]  P. Roughley,et al.  Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. , 1995, The Biochemical journal.

[22]  L. Lohmander,et al.  The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. , 1993, Arthritis and rheumatism.

[23]  H. Roos,et al.  Stromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee joint fluid after injury. , 1993, The Journal of rheumatology.

[24]  K. Stüwe,et al.  Activation of procathepsin B in human hepatoma cells: the conversion into the mature enzyme relies on the action of cathepsin B itself. , 1993, The Biochemical journal.

[25]  L. Lohmander,et al.  Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. , 1993, Arthritis and rheumatism.

[26]  P. Roughley,et al.  Monoclonal antibodies recognizing protease-generated neoepitopes from cartilage proteoglycan degradation. Application to studies of human link protein cleavage by stromelysin. , 1992, The Journal of biological chemistry.

[27]  P. Roughley,et al.  Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage. , 1992, The Journal of clinical investigation.

[28]  H. C. Robinson,et al.  Mechanism of catabolism of aggrecan by articular cartilage. , 1992, Archives of biochemistry and biophysics.

[29]  T. Hardingham,et al.  Proteoglycans: many forms and many functions , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  M. Lark,et al.  Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage. , 1992, The Journal of biological chemistry.

[31]  J. Sandy,et al.  Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. , 1991, The Journal of biological chemistry.

[32]  K. Doege,et al.  Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms. , 1991, The Journal of biological chemistry.

[33]  P. Dieppe,et al.  Human cartilage is degraded by rheumatoid arthritis synovial fluid but not by recombinant cytokines in vitro , 1991, Clinical and experimental immunology.

[34]  H. Muir,et al.  Hyaluronic acid in human articular cartilage. Age-related changes in content and size. , 1988, The Biochemical journal.

[35]  P. Roughley,et al.  Treatment of cartilage proteoglycan aggregate with hydrogen peroxide. Relationship between observed degradation products and those that occur naturally during aging. , 1987, The Biochemical journal.

[36]  P. Roughley,et al.  Ageing and the aggregating proteoglycans of human articular cartilage. , 1986, Clinical science.

[37]  A. Ratcliffe,et al.  Articular cartilage cultured with interleukin 1. Increased release of link protein, hyaluronate-binding region and other proteoglycan fragments. , 1986, The Biochemical journal.

[38]  R W Farndale,et al.  A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. , 1982, Connective tissue research.

[39]  P. Roughley,et al.  Age-related changes in the structure of the proteoglycan subunits from human articular cartilage. , 1980, The Journal of biological chemistry.

[40]  J. Annas.  On the ”Intermediates“ , 1975 .

[41]  J. McCord.  Free Radicals and Inflammation: Protection of Synovial Fluid by Superoxide Dismutase , 1974, Science.